Status:
COMPLETED
A Clinical Evaluation of the Tension-Free Vaginal Tape Obturator System For Treatment of Stress Urinary Incontinence (Urinary Leakage)
Lead Sponsor:
Ethicon, Inc.
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Stress urinary incontinence affects nearly 30 million women worldwide and the main goal of surgical treatment is to stop urinary incontinence (urinary leakage) that occurs with physical activity, coug...
Eligibility Criteria
Inclusion
- Patient has objective demonstrable signs of stress urinary incontinence (SUI), including patients with ISD. Objective testing includes: standing stress test, urodynamics evaluation, or pad test.
- Patient is age 18 or older.
- Patient had a hysterectomy, tubal ligation or is otherwise incapable of pregnancy, or had a negative pregnancy test prior to study entry and has decided to cease childbearing.
- Patient agrees to participate in the study, including completion of all study-related procedures and evaluations, and documents this agreement by signing the IRB/EC-approved informed consent.
Exclusion
- Patient has an associated or suspected neurological disease.
- Patient is on anti-coagulation therapy.
- Patient has received an investigational drug or device in the past 60 days.
- For patients having URP measurements at selected sites:
- Patient has an active lesion or present injury to perineum or urethra.Patient has a urethral obstruction.
- Patient has an unreduced cystocele \> Stage 1. (Reduction of prolapse prior to URP testing is required.) Reduction of Cystocele (if applicable). Patients should be seated in a semi-fowler's position with head of bed at 40-60 degrees.
- Carefully place a half of a speculum into the vagina, reducing prolapse to less than stage 1. Be careful not to over extend or elongate the vaginal length.
- The half of a speculum must be placed with pressure emphasis on the posterior and apical areas. Anterior wall pressure or urethral pressure must be avoided at all times.
- The subject has active infection upon urine dipstick analysis, defined as ≥+1 leukocytes or ≥+1 nitrates (Must reschedule appointment after UTI resolves.)
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00196521
Start Date
January 1 2005
End Date
March 1 2007
Last Update
December 13 2007
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Urogynecology Associates of CO
Denver, Colorado, United States, 80220
2
Bladder Control Center
Norwalk, Connecticut, United States, 06850
3
Urogynecology Specialists of Kenuckiana
Louisville, Kentucky, United States, 40207
4
Greater Baltimore Medical Center
Baltimore, Maryland, United States, 21204